| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Chief Legal Officer | SVP, GC &Secretary +1 more
3 companies
Keating Laurie is a Director at IMRX with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 24 sells.
Estimated insider holdings value: $3.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Legal Officer | Sale+OE | 10,000 | $129.00 | $1,290,000.00 | -44.9% | |
| Jan 29, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Legal Officer | Sale+OE | 6,337 | $119.00 | $754,103.00 | -42.4% | |
| Jan 27, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Legal Officer | Sale+OE | 41,037 | $117.70 | $4,829,969.73 | -22.6% | |
| Jun 20, 2018 | ALNY Alnylam Pharmaceuticals, Inc. | SVP, GC &Secretary | Sale+OE | 1,563 | $105.04 | $164,177.52 | -9.7% | |
| Mar 20, 2018 | ALNY Alnylam Pharmaceuticals, Inc. | SVP, GC &Secretary | Sale+OE | 1,562 | $149.83 | $234,032.98 | -2.0% | |
| Mar 13, 2018 | ALNY Alnylam Pharmaceuticals, Inc. | SVP, GC &Secretary | Sale+OE | 20,000 | $145.00 | $2,900,000.00 | -40.8% | |
| Dec 20, 2017 | ALNY Alnylam Pharmaceuticals, Inc. | SVP, GC &Secretary | Sale+OE | 6,249 | $121.20 | $757,398.40 | -14.4% | |
| Dec 1, 2017 | ALNY Alnylam Pharmaceuticals, Inc. | SVP, GC And Secretary | Sale+OE | 30,000 | $135.89 | $4,076,823.30 | -18.7% | |
| May 30, 2017 | ALNY Alnylam Pharmaceuticals, Inc. | SVP, GC And Secretary | Buy | 11,500 | $65.35 | $751,502.00 | New |